Compare · SNN vs ZJYL
SNN vs ZJYL
Side-by-side comparison of Smith & Nephew SNATS Inc. (SNN) and JIN MEDICAL INTERNATIONAL LTD. (ZJYL): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both SNN and ZJYL operate in Industrial Specialties (Health Care), so they compete in similar markets.
- SNN is the larger of the two at $12.41B, about 57.1x ZJYL ($217.3M).
- SNN has been more active in the news (14 items in the past 4 weeks vs 2 for ZJYL).
- SNN has more recent analyst coverage (25 ratings vs 0 for ZJYL).
- Company
- Smith & Nephew SNATS Inc.
- JIN MEDICAL INTERNATIONAL LTD.
- Price
- -
- -
- Market cap
- $12.41B
- $217.3M
- 1M return
- -
- +35.78%
- 1Y return
- -
- -83.61%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NYSE
- NASDAQ
- IPO
- 2023
- News (4w)
- 14
- 2
- Recent ratings
- 25
- 0
Smith & Nephew SNATS Inc.
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products for surgeons, including instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder, as well as meniscal repair systems. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, including biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.
Latest SNN
- SEC Form 6-K filed by Smith & Nephew SNATS Inc.
- SEC Form 6-K filed by Smith & Nephew SNATS Inc.
- SEC Form 6-K filed by Smith & Nephew SNATS Inc.
- Smith+Nephew and Imperial College London launch centre to accelerate innovation in surgical robotics
- Smith+Nephew’s new FLOW FLEXTEND™ COBLATION™ Wand improves access¹* and resection efficiency²** for complex hip procedures vs. fixed-angle options
- SEC Form 6-K filed by Smith & Nephew SNATS Inc.
- SEC Form 6-K filed by Smith & Nephew SNATS Inc.
- SEC Form 6-K filed by Smith & Nephew SNATS Inc.
- Smith & Nephew downgraded by Analyst
- Smith+Nephew celebrates mobility, recovery and football's greatest traditions during Pro Football Hall of Fame Enshrinement Week
Latest ZJYL
- SEC Form 6-K filed by JIN MEDICAL INTERNATIONAL LTD.
- JIN MEDICAL INTERNATIONAL LTD. Reports First Half of Fiscal Year 2026 Financial Results
- SEC Form 6-K filed by JIN MEDICAL INTERNATIONAL LTD.
- SEC Form 3 filed by new insider Xue Ning
- SEC Form 6-K filed by JIN MEDICAL INTERNATIONAL LTD.
- Amendment: SEC Form 6-K/A filed by JIN MEDICAL INTERNATIONAL LTD.
- SEC Form 6-K filed by JIN MEDICAL INTERNATIONAL LTD.
- SEC Form 6-K filed by JIN MEDICAL INTERNATIONAL LTD.
- SEC Form 3 filed by new insider Franklin Oliver St Clair Jr
- SEC Form 3 filed by new insider Tong James Jiayuan